{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:18:49Z","timestamp":1791425929274,"version":"4.3.3"},"update-to":[{"DOI":"10.1002\/14651858.cd009029","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T00:00:00Z","timestamp":1372982400000}}],"reference-count":77,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009029.pub2","type":"journal-article","created":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T08:14:02Z","timestamp":1373012042000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Vaccines for preventing enterotoxigenic\n                    <i>Escherichia coli<\/i>\n                    (ETEC) diarrhoea"],"prefix":"10.1002","volume":"2013","author":[{"given":"Tanvir","family":"Ahmed","sequence":"first","affiliation":[{"name":"Variation Biotechnologies Inc.; 1740 Woodroffe Ave, Building 400 Ottawa Ontario Canada K2G 3R8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taufiqur R","family":"Bhuiyan","sequence":"additional","affiliation":[{"name":"International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b); Centre for Vaccine Sciences; 68 Shaheed Tajuddin Ahamed Sharani, Mohakhali Dhaka Bangladesh 1212"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Zaman","sequence":"additional","affiliation":[{"name":"International Centre for Diarrhoeal Disease Research, Bangladesh; Child Health Unit; 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali Dhaka Bangladesh 1212"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sinclair","sequence":"additional","affiliation":[{"name":"Liverpool School of Tropical Medicine; Department of Clinical Sciences; Pembroke Place Liverpool UK L3 5QA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[{"name":"International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b); Centre for Vaccine Sciences; 68 Shaheed Tajuddin Ahamed Sharani, Mohakhali Dhaka Bangladesh 1212"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,7,5]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD009029.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","article-title":"Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial","volume":"158","author":"Clemens","year":"1988","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD009029.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/ije\/18.2.440","article-title":"Exclusion of clinically atypical or microbiologically mixed diarrhoeal episodes from outcome events in a field trial of oral cholera vaccines","volume":"18","author":"Clemens","year":"1989","journal-title":"International Journal of Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD009029.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1128\/IAI.68.8.4492-4497.2000","article-title":"Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Israeli young adults","volume":"68","author":"Cohen","year":"2000","journal-title":"Infection & Immunity"},{"issue":"8","key":"10.1002\/14651858.CD009029.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1128\/IAI.68.8.4492-4497.2000","article-title":"Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Israeli young adults","volume":"68","author":"Cohen","year":"2000","journal-title":"Infection & Immunity"},{"issue":"9629","key":"10.1002\/14651858.CD009029.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(08)60839-9","article-title":"Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial","volume":"371","author":"Frech","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD009029.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/514227","article-title":"Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli","volume":"177","author":"Freedman","year":"1998","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD009029.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/IAI.69.5.2853-2857.2001","article-title":"Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenicEscherichia coli plus cholera toxin B subunit vaccine","volume":"69","author":"Hall","year":"2001","journal-title":"Infection & Immunity"},{"issue":"5","key":"10.1002\/14651858.CD009029.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/IAI.69.5.2853-2857.2001","article-title":"Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenicEscherichia coli plus cholera toxin B subunit vaccine","volume":"69","author":"Hall","year":"2001","journal-title":"Infection & Immunity"},{"issue":"5","key":"10.1002\/14651858.CD009029.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/IAI.69.5.2853-2857.2001","article-title":"Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenicEscherichia coli plus cholera toxin B subunit vaccine","volume":"69","author":"Hall","year":"2001","journal-title":"Infection & Immunity"},{"issue":"2-3","key":"10.1002\/14651858.CD009029.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0264-410X(97)00169-2","article-title":"Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine","volume":"16","author":"Jertborn","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD009029.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1128\/CDLI.8.2.424-428.2001","article-title":"Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine","volume":"8","author":"Jertborn","year":"2001","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"issue":"43","key":"10.1002\/14651858.CD009029.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1016\/j.vaccine.2005.05.022","article-title":"Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study","volume":"23","author":"Leyten","year":"2005","journal-title":"Vaccine"},{"issue":"18","key":"10.1002\/14651858.CD009029.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1016\/j.vaccine.2007.01.043","article-title":"Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study","volume":"25","author":"McKenzie","year":"2007","journal-title":"Vaccine"},{"issue":"36","key":"10.1002\/14651858.CD009029.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1016\/j.vaccine.2008.06.064","article-title":"A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC","volume":"26","author":"McKenzie","year":"2008","journal-title":"Vaccine"},{"issue":"8778","key":"10.1002\/14651858.CD009029.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0140-6736(91)92590-X","article-title":"Prevention of travellers' diarrhoea by oral B-subunit\/whole-cell cholera vaccine","volume":"338","author":"Peltola","year":"1991","journal-title":"Lancet"},{"issue":"19-20","key":"10.1002\/14651858.CD009029.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/S0264-410X(03)00077-X","article-title":"Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of age","volume":"21","author":"Qadri","year":"2003","journal-title":"Vaccine"},{"issue":"10","key":"10.1002\/14651858.CD009029.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.vaccine.2005.08.110","article-title":"Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groups","volume":"24","author":"Qadri","year":"2006","journal-title":"Vaccine"},{"issue":"22","key":"10.1002\/14651858.CD009029.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1016\/j.vaccine.2007.03.034","article-title":"Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. coli diarrhoea of travellers to Guatemala and Mexico","volume":"25","author":"Sack","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD009029.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/517812","article-title":"Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults","volume":"177","author":"Savarino","year":"1998","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD009029.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1086\/314543","article-title":"Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group","volume":"179","author":"Savarino","year":"1999","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD009029.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1086\/314543","article-title":"Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group","volume":"179","author":"Savarino","year":"1999","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD009029.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00006454-200204000-00012","article-title":"Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants","volume":"21","author":"Savarino","year":"2002","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"1","key":"10.1002\/14651858.CD009029.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1708-8305.1995.tb00615.x","article-title":"Safety, immunogenicity, and protective efficacy of the whole-cell\/recombinant B subunit (WC\/rBS) oral cholera vaccine against travelers' diarrhea","volume":"2","author":"Scerpella","year":"1995","journal-title":"Journal of Travel Medicine"},{"issue":"6","key":"10.1002\/14651858.CD009029.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1086\/315157","article-title":"Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal","volume":"180","author":"Tacket","year":"1999","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD009029.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2310\/7060.2000.00007","article-title":"Double-blind, randomized, placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B-subunit-inactivated whole cell vaccine against travelers' diarrhea (preliminary report)","volume":"7","author":"Wiedermann","year":"2000","journal-title":"Journal of Travel Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009029.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/499821","article-title":"Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children","volume":"193","author":"Ahmed","year":"2006","journal-title":"Journal of Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD009029.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1128\/IAI.66.7.3311-3316.1998","article-title":"Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin a responses in blood","volume":"66","author":"Ahren","year":"1998","journal-title":"Infection and Immunity"},{"issue":"18","key":"10.1002\/14651858.CD009029.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1016\/j.vaccine.2005.07.022","article-title":"Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of\u00a0enterotoxigenic Escherichia coli\u00a0in challenged and vaccinated volunteers","volume":"24","author":"Carpenter","year":"2006","journal-title":"Vaccine"},{"issue":"12","key":"10.1002\/14651858.CD009029.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1086\/386288","article-title":"Development of pathogenicity-driven definitions of outcomes for a field trial of a killed oral vaccine against enterotoxigenic Escherichia coli in Egypt: application of an evidence-based method\u00a0","volume":"189","author":"Clemens","year":"2004","journal-title":"Journal of Infectious Disease"},{"issue":"1","key":"10.1002\/14651858.CD009029.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1128\/IAI.01131-06","article-title":"Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli","volume":"75","author":"Coster","year":"2007","journal-title":"Infection and Immunity"},{"issue":"11","key":"10.1002\/14651858.CD009029.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/gut.2006.112805","article-title":"Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation","volume":"56","author":"Daley","year":"2007","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD009029.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/0016-5085(84)90091-X","article-title":"Administration of purified colonization factor antigens (CFA\/I, CFA\/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli","volume":"87","author":"Evans","year":"1984","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD009029.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1574-6968.1988.tb02363.x","article-title":"Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA\/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes","volume":"1","author":"Evans","year":"1988","journal-title":"FEMS Microbiology Immunology"},{"issue":"1","key":"10.1002\/14651858.CD009029.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1574-6968.1988.tb02485.x","article-title":"Immunoprotective oral whole cell vaccine for enterotoxigenic Escherichia coli diarrhea prepared by in situ destruction of chromosomal and plasmid DNA with colicin E2","volume":"1","author":"Evans","year":"1988","journal-title":"FEMS Microbiology Immunology"},{"issue":"5","key":"10.1002\/14651858.CD009029.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/IAI.01740-06","article-title":"Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum","volume":"75","author":"Glenn","year":"2007","journal-title":"Infection and Immunity"},{"issue":"4","key":"10.1002\/14651858.CD009029.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1128\/IAI.70.4.1874-1880.2002","article-title":"Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously","volume":"70","author":"Guere\u00f1a-Burgue\u00f1o","year":"2002","journal-title":"Infection & Immunity"},{"issue":"1-2","key":"10.1002\/14651858.CD009029.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0264-410X(02)00348-1","article-title":"Calibrated serological techniques demonstrate significant different serum response rates to an oral killed\u00a0cholera vaccine\u00a0between Swedish and Nicaraguan children","volume":"22","author":"Hallander","year":"2002","journal-title":"Vaccine"},{"issue":"13","key":"10.1002\/14651858.CD009029.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0264-410X(92)90324-D","article-title":"An oral B subunit: whole cell vaccine against cholera","volume":"10","author":"Holmgren","year":"1992","journal-title":"Vaccine"},{"issue":"5-6","key":"10.1002\/14651858.CD009029.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0264-410X(02)00613-8","article-title":"Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen","volume":"21","author":"Katz","year":"2003","journal-title":"Vaccine"},{"issue":"21","key":"10.1002\/14651858.CD009029.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.vaccine.2007.03.007","article-title":"Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans","volume":"25","author":"Khan","year":"2007","journal-title":"Vaccine"},{"issue":"8479","key":"10.1002\/14651858.CD009029.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(86)92930-2","article-title":"Immunisation of volunteers with a synthetic peptide vaccine for enterotoxigenic Escherichia coli","volume":"1","author":"Klipstein","year":"1986","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD009029.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1128\/CVI.00491-07","article-title":"Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G","volume":"15","author":"Lapa","year":"2008","journal-title":"Clinical and Vaccine Immunology"},{"key":"10.1002\/14651858.CD009029.pub2-BIB0043|cit43","first-page":"83","article-title":"Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man","volume":"33","author":"Levine","year":"1982","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD009029.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1128\/IAI.74.2.994-1000.2006","article-title":"Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults","volume":"74","author":"McKenzie","year":"2006","journal-title":"Infection and immunity"},{"issue":"8","key":"10.1002\/14651858.CD009029.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1128\/IAI.00474-06","article-title":"Homologous and cross-reactive immune responses to enterotoxigenic Escherichia coli colonization factors in Bangladeshi children","volume":"74","author":"Qadri","year":"2006","journal-title":"Infection and Immunity"},{"issue":"3-4","key":"10.1002\/14651858.CD009029.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0264-410X(02)00467-X","article-title":"Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori","volume":"21","author":"Sougioultzis","year":"2002","journal-title":"Vaccine"},{"issue":"14","key":"10.1002\/14651858.CD009029.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0264-410X(94)80038-2","article-title":"Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA\/II encapsulated in biodegradable microspheres","volume":"12","author":"Tacket","year":"1994","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD009029.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/IAI.74.2.1062-1071.2006","article-title":"Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA\/I","volume":"74","author":"Turner","year":"2006","journal-title":"Infection and immunity"},{"issue":"11","key":"10.1002\/14651858.CD009029.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/oxfordjournals.aje.a116819","article-title":"Immunologic response to oral cholera vaccination in a crossover study: a novel placebo effect","volume":"138","author":"Wasserman","year":"1993","journal-title":"American Journal of Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009029.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1128\/IAI.67.12.6234-6241.1999","article-title":"Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees","volume":"67","author":"Wenneras","year":"1999","journal-title":"Infection and Immunity"},{"issue":"2","key":"10.1002\/14651858.CD009029.pub2-BIB0051|cit51","first-page":"8309","article-title":"Nutritional status, body size and severity of diarrhoea associated with rotavirus or enterotoxigenic Escherichia coli","volume":"87","author":"Black","year":"1984","journal-title":"Journal of Tropical Medicine & Hygiene"},{"issue":"12","key":"10.1002\/14651858.CD009029.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1128\/CVI.00364-12","article-title":"The oral, live attenuated enterotoxigenic Eschericia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease","volume":"19","author":"Darsley","year":"2012","journal-title":"Clinical and Vaccine Immunology"},{"issue":"9","key":"10.1002\/14651858.CD009029.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2036.2008.03647.x","article-title":"Systematic review: prevention of\u00a0travellers'\u00a0diarrhoea","volume":"27","author":"DuPont","year":"2008","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD009029.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/infdis\/141.1.64","article-title":"Adenosine diphosphate-ribosylation of adenylate cyclase catalyzed by heat-labile enterotoxin of Escherichia coli: comparison with cholera toxin","volume":"141","author":"Gill","year":"1980","journal-title":"Journal of Infectious Diseases"},{"issue":"7650","key":"10.1002\/14651858.CD009029.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD009029.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4269\/ajtmh.2008.79.708","article-title":"Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh","volume":"79","author":"Harris","year":"2008","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"12","key":"10.1002\/14651858.CD009029.pub2-BIB0057|cit57","first-page":"2118","article-title":"A combination\u00a0vaccine\u00a0consisting of three live attenuated\u00a0enterotoxigenic Escherichia coli\u00a0strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults","volume":"18","author":"Harro","year":"2011","journal-title":"Clinical\u00a0and Vaccine\u00a0Immunology"},{"key":"10.1002\/14651858.CD009029.pub2-BIB0058|cit58","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"issue":"2","key":"10.1002\/14651858.CD009029.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2004.11.009","article-title":"Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA","volume":"97","author":"Holmgren","year":"2005","journal-title":"Immunology Letters"},{"issue":"3","key":"10.1002\/14651858.CD009029.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.coi.2012.03.014","article-title":"Vaccines against mucosal infections","volume":"24","author":"Holmgren","year":"2012","journal-title":"Current Opinion in Immunology"},{"issue":"5","key":"10.1002\/14651858.CD009029.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1586\/14760584.7.5.561","article-title":"Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera","volume":"7","author":"Jelinek","year":"2008","journal-title":"Expert Review of Vaccines"},{"issue":"2","key":"10.1002\/14651858.CD009029.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0264-410X(92)90030-N","article-title":"Safety and immunogenicity of an oral recombinant cholera b subunit-whole cell vaccine in Swedish volunteers","volume":"10","author":"Jertborn","year":"1992","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD009029.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.18.3.465-483.2005","article-title":"Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention","volume":"18","author":"Qadri","year":"2005","journal-title":"Clinical Microbiology Review"},{"issue":"8","key":"10.1002\/14651858.CD009029.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1128\/IAI.00459-07","article-title":"Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh","volume":"75","author":"Qadri","year":"2007","journal-title":"Infection and Immunity"},{"issue":"4","key":"10.1002\/14651858.CD009029.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/427662","article-title":"Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea","volume":"191","author":"Rao","year":"2005","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD009029.pub2-BIB0066|cit66","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"6","key":"10.1002\/14651858.CD009029.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.4269\/ajtmh.2006.74.1067","article-title":"Diarrheal epidemics in Dhaka, Bangladesh, during three consecutive floods: 1988, 1998, and 2004","volume":"74","author":"Schwartz","year":"2006","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD009029.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2310\/7060.2005.12207","article-title":"Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea","volume":"12","author":"Steffen","year":"2005","journal-title":"Journal of Travel Medicine"},{"issue":"6","key":"10.1002\/14651858.CD009029.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/infdis\/149.6.884","article-title":"Mucosal\u00a0antitoxic\u00a0and\u00a0antibacterial\u00a0immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine","volume":"149","author":"Svennerholm","year":"1984","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD009029.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1586\/14760584.7.6.795","article-title":"Vaccines against enterotoxigenic Escherichia coli","volume":"7","author":"Svennerholm","year":"2008","journal-title":"Expert Review of Vaccines"},{"issue":"48","key":"10.1002\/14651858.CD009029.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"8863","DOI":"10.1016\/j.vaccine.2011.09.096","article-title":"Construction of a non-toxigenic\u00a0Escherichia\u00a0coli\u00a0oral\u00a0vaccine\u00a0strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice","volume":"29","author":"Tobias","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1002\/14651858.CD009029.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00253-012-3930-6","article-title":"Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates","volume":"93","author":"Tobias","year":"2012","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"14","key":"10.1002\/14651858.CD009029.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/j.vaccine.2006.12.028","article-title":"Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease","volume":"25","author":"Walker","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1002\/14651858.CD009029.pub2-BIB0074|cit74","first-page":"370","article-title":"Prevalence of enterotoxigenic Escherichia coli-associated diarrhoea and carrier state in the developing world","volume":"22","author":"Wenner\u00e5s","year":"2004","journal-title":"Journal of Health, Population and Nutrition"},{"key":"10.1002\/14651858.CD009029.pub2-BIB0075|cit75","unstructured":"WHO Diarrhoeal diseases (updated February 2009) http:\/\/www.who.int\/vaccine_research\/diseases\/diarrhoeal\/en\/index4.html 2009"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD009029.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00508-009-1228-1","article-title":"Travellers\u2019 diarrhoea \u2013 pros and cons of different prophylactic measures","volume":"121","author":"Wagner","year":"2009","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"4","key":"10.1002\/14651858.CD009029.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.10.4.569","article-title":"Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli","volume":"10","author":"Wolf","year":"1997","journal-title":"Clinical Microbiology Review"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009029.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T05:47:07Z","timestamp":1746510427000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009029.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,5]]},"references-count":77,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009029.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718026763.793484170","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,5]]}}}